Ftse Mib
32.669,30
-2,80%
DAX
18.002,02
-1,43%
S&P 500
5.419,75
-0,26%
NASDAQ
17.642,68
-0,14%
Bitcoin
65.852,86
-1,36%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ HilleVax Inc (HLVX) HilleVax Inc (HLVX) Notizie

HilleVax Inc

HLVX
14,69
-0,11 (-0,74%)
Ultimo aggiornamento: 18:06:50
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/6/202422:05EDGAR2Form 8-K - Current report
10/5/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
09/5/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:10EDGAR2Form 8-K - Current report
09/5/202422:05GLOBEHilleVax Reports First Quarter 2024 Financial Results and..
20/3/202421:00GLOBEHilleVax Reports Full Year 2023 Financial Results and..
13/2/202401:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/2/202422:05GLOBEHilleVax to Present at Guggenheim 6th Annual Biotechnology..
02/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202423:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/1/202413:49DJNHilleVax Taps Sean McLoughlin as Chief Operating Officer
18/1/202413:05EDGAR2Form 8-K - Current report
18/1/202413:00GLOBEHilleVax Announces Executive Management Appointment of Sean..
08/1/202413:05EDGAR2Form 8-K - Current report
08/1/202413:00GLOBEHilleVax and Kangh Announce Exclusive License Agreement for..
04/1/202400:28GLOBEHilleVax to Present at the 42nd Annual J.P. Morgan..
18/12/202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202323:28EDGAR2Form 144 - Report of proposed sale of securities
08/12/202323:11EDGAR2Form 8-K - Current report
05/12/202322:56EDGAR2Form 144 - Report of proposed sale of securities
05/12/202322:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202303:14EDGAR2Form 144 - Report of proposed sale of securities
20/11/202322:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/11/202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202322:10EDGAR2Form 8-K - Current report
09/11/202322:05GLOBEHilleVax Reports Third Quarter 2023 Financial Results and..
01/11/202321:48GLOBEHilleVax to Present at Upcoming Investor Conferences
26/9/202322:01GLOBEHilleVax to Participate in Fireside Chat at the 2023 Cantor..
25/9/202313:00GLOBEHilleVax Announces Closing of Public Offering of Common..
20/9/202322:03EDGAR2Form 8-K - Current report
20/9/202322:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/9/202302:05GLOBEHilleVax Announces Pricing of Public Offering of Common..
19/9/202322:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/9/202322:09GLOBEHilleVax Announces Proposed Public Offering of Common Stock
14/8/202313:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202313:05EDGAR2Form 8-K - Current report
14/8/202313:00GLOBEHilleVax Reports Second Quarter 2023 Financial Results and..
Apertura: 14,61 Min: 14,39 Max: 14,89
Chiusura: 14,80

La tua Cronologia

NASDAQ
HLVX
HilleVax
NYSE
KVB
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network